Performant Financial (PFMT) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue increased 22% year-over-year to $33.3 million, driven by 29% growth in healthcare payment integrity services and strong commercial client expansion.

• Adjusted EBITDA improved to $3.3 million from a $1.2 million loss in Q1 2024, with net loss narrowing to $81 thousand, and adjusted net income reaching $1.2 million ($0.02/share).

• Record 13 new commercial program implementations in Q1, expected to add $4.5–$5.0 million in annualized revenue.

• Customer Care/Outsourced Services revenue declined 95% due to contract expiration, with the company now focused solely on healthcare services.

• Strategic focus on technology, client partnerships, and operational improvements, including Project Turing and the first state Medicaid contract in New York.

Financial highlights

• Total Q1 2025 revenue: $33.3 million, up 22% year-over-year; healthcare revenue grew 29% to $33.2 million.

• Claims-based revenue: $17.1 million, up 38%; eligibility-based revenue: $16.1 million, up 20% year-over-year.

• Adjusted EBITDA was $3.3 million, with an adjusted EBITDA margin of approximately 10%.

• Cash provided by operating activities was $2.9 million, with cash and cash equivalents totaling $10.0 million at quarter end.

• Operating expenses increased to $33.1 million, mainly due to scaling implementations and technology investments.

Outlook and guidance

• Full-year 2025 revenue guidance raised to $133–$135 million; adjusted EBITDA guidance increased to $9–$10 million.

• Expects each quarter to be EBITDA positive moving forward, with free cash flow generation anticipated.

• Revenue growth to be strongest in Q1, with some impact from RAC Region 5 wind-down and New York State RAC ramp-up in later quarters.

• No meaningful revenue expected from Customer Care/Outsourced Services in 2025.

• Management projects sufficient cash flows from operations to fund ongoing business and liquidity needs.